Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Sales | 56,036 | 59,988 | 90,142 | 88,478 | 69,555 |
Cost of Goods | 80,111 | 24,239 | 59,089 | 18,613 | 38,147 |
Gross Profit | -24,075 | 35,749 | 31,053 | 69,865 | 31,408 |
Operating Expenses | 62,823 | 94,083 | 204,961 | 129,603 | 126,446 |
Operating Income | -86,787 | -58,095 | -173,819 | -59,125 | -94,891 |
Interest Expense | 2,317 | 2,274 | 2,308 | 1,972 | -307 |
Other Income | 720 | 410 | 376 | 350 | -1,651 |
Pre-tax Income | -88,384 | -59,959 | -175,751 | -60,747 | -96,235 |
Income Tax | N/A | N/A | N/A | N/A | -1,752 |
Net Income Continuous | -88,384 | -59,959 | -175,751 | -60,747 | -94,483 |
Net Income | $-88,384 | $-59,959 | $-175,751 | $-60,747 | $-94,483 |
EPS Basic Total Ops | -0.61 | -0.42 | -1.28 | -0.47 | -0.79 |
EPS Basic Continuous Ops | -0.60 | -0.42 | -1.28 | -0.47 | -0.79 |
EPS Diluted Total Ops | -0.61 | -0.42 | -1.28 | -0.47 | -0.79 |
EPS Diluted Continuous Ops | -0.60 | -0.42 | -1.28 | -0.47 | -0.79 |
EBITDA(a) | $-79,079 | $-51,504 | $-48,673 | $-49,500 | $-85,229 |